ScreenerHero
CHEMMChemoMetec A/S
CPH · DK · Technology · Medical Devices · chemometec.com
486.60DKK+2.40%Mkt Cap: 1.20B $P/E: 46.63

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$198.81BUSDP/E 36.9
SYK
STRYKER CORP. R
$120.66BUSDP/E 34.7
SYK
Stryker Corporation
$125.70BUSDP/E 33.9
2M6
Medtronic plc
$111.66BUSDP/E 24.9
BSX
Boston Scientific Corporation
$75.37BUSDP/E 21.1
EW
Edwards Lifesciences Corporation
$53.13BUSDP/E 54.9
SHL
Siemens Healthineers AG
$48.43BUSDP/E 19.9
GEHC
GE HealthCare Technologies Inc. Common Stock
$33.94BUSDP/E 17.2
DXCM
DexCom, Inc.
$33.92BUSDP/E 35.5
PHIA
Koninklijke Philips N.V.
$25.21BUSDP/E 20.8
ZBH
Zimmer Biomet Holdings, Inc.
$19.21BUSDP/E 24.5
SOON
Sonova Holding AG
$16.48BUSDP/E 26.9
PEN
Penumbra, Inc.
$12.87BUSDP/E 80.5
SN
Smith & Nephew plc
$11.52BUSDP/E 19.9
GMED
Globus Medical, Inc.
$11.86BUSDP/E 22.6
GKOS
Glaukos Corp
$11.18BUSD
EUZ
Eckert & Ziegler SE
$10.01BUSDP/E 17.1
PODD
Insulet Corporation
$10.51BUSDP/E 28.4
BIO
Bio-Rad Laboratories, Inc. Class A
$9.75BUSDP/E 44.3
MASI
Masimo Corporation
$9.42BUSDP/E 44.4

Key Statistics

Company
Market Cap1.20B $
Enterprise Value1.17B $
Revenue (TTM)71.82M $
Gross Profit67.80M $
Net Income (TTM)27.15M $
Revenue/Share4.127 USD
Last Price486.60 DKK
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees172
CountryDK
SectorTechnology
IndustryMedical Devices
ISINDK0060055861
Valuation
P/E (Trailing)46.63
P/E (Forward)37.98
PEG—
EV/EBITDA32.77
EV/Revenue16.22
P/S16.77
P/B12.67
EPS (TTM)10.19
EPS (Forward)12.51
52W Range
235.2044% of range804.00
52W High804.00 DKK
52W Low235.20 DKK
Profitability
Gross Margin93.93%
Oper. Margin48.42%
EBITDA Margin49.51%
Profit Margin37.61%
ROE27.68%
ROA22.51%
Growth
Revenue Growth-1.00%
Earnings Growth-9.10%
Cash Flow & Leverage
Operating CF30.22M $
CapEx (TTM)9.43M $
FCF Margin25.06%
FCF Yield1.49%
Net Debt-39.25M $
Net Debt/EBITDA-1.10
Balance Sheet
Debt/Equity0.01
Current Ratio3.93
Quick Ratio3.02
Book Value/Sh37.50 DKK
Cash/Share15.78 DKK
Dividends
Fwd Div Rate7.000 DKK
Trail. Div Rate7.000 DKK
Div. Yield1.45%
5Y Avg Yield—
Payout Ratio68.83%
Ex-Div DateOct 10, 2025
Pay Date—
Analyst Consensus
Rating—
Target (Mean)578.33 DKK
Upside (mean)+18.9%
Target Range450.00 DKK – 650.00 DKK
DKK450.00+18.9% to meanDKK650.00
# Analysts3
Ownership
Shares Out.17.40M
Float16.74M
Insiders3.73%
Institutions53.63%
Technical
SMA 50411.18 (+18.3%)
SMA 200480.34 (+1.3%)
Beta1.38
S&P 52W Chg18.16%
Avg Vol (30d)54.54K
Avg Vol (10d)85.44K
Technical Indicators
RSI (14)69.1
MACD19.5849
MACD Signal16.3106
MACD Hist.+3.2744
BB Upper494.86 DKK
BB Middle439.75 DKK
BB Lower384.64 DKK
BB Width25.06%
ATR (14)21.80 DKK
Vol Ratio (20d)1.30x